Takeda Pharmaceutical
308 hedge funds and large institutions have $1.9B invested in Takeda Pharmaceutical in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 90 increasing their positions, 89 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
308
Holders Change
+2
Holders Change %
+0.65%
% of All Funds
6.23%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
37
Increased
90
Reduced
89
Closed
34
Calls
$54M
Puts
$63.1M
Net Calls
-$9.06M
Net Calls Change
-$430K
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$20.6M |
| 2 |
Goldman Sachs
New York
|
+$11.8M |
| 3 |
GCM
Glenview Capital Management
New York
|
+$10.6M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$7.66M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$6.29M |
Top Sellers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$25M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$18M |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
-$16.1M |
| 4 |
AC
Adelphi Capital
London,
United Kingdom
|
-$15.7M |
| 5 |
GC
GMT Capital
Atlanta,
Georgia
|
-$13M |
